RecruitingNot Applicable

Supervised Endoscopic Tele-controlled Intelligent Lithotripsy

Hong Kong15 participantsStarted 2026-02-15

Plain-language summary

This is a phase I feasibility study to investigate the use of a novel intelligent robotic retrograde intrarenal surgery (RIRS) platform. The TaloStone T1000 RIRS system can manipulate the flexible ureteroscope, with remote control of the instruments (laser fibre or basket) and ureteral access sheath movements. Beyond teleoperation, the TaloStone T1000 RIRS system integrates AI perception models and decision-making algorithms to enable the supervised autonomous execution of critical tasks within the RIRS workflow.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult patients \>18 years old
✓. Renal stone(s) less than 1cm 2cm in maximal length
✓. Clinically indicated for RIRS
✓. Willingness to participate as demonstrated by giving informed consent

Exclusion criteria

✕. Patients with no preoperative CT imaging available
✕. Patients who are not recommended to receive RIRS
✕. Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
✕. Untreated active infection
✕. Un-corrected coagulopathy
✕. Presence of another malignancy or distant metastasis
✕. Emergency surgery
✕. Vulnerable population (e.g. mentally disabled, pregnant)

What they're measuring

Success rate

Timeframe: Intra-operative

Trial details

NCT IDNCT07411391

SponsorChinese University of Hong Kong

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

Alex Qinyang Liu, MBBS, MSc, FRCSEd

852+35052625 alexliu@surgery.cuhk.edu.hk

View on ClinicalTrials.gov More Renal Stone trials